What is Belimumab?

Category: Prescription Drugs

Most popular types: Benlysta

false

Belimumab is a medication used for the treatment of systemic lupus erythematosus. It works by decreasing the activity of a certain type of cell in the immune system so the body’s overall autoimmune response is lowered. It is administered through an intravenous (IV) infusion.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Systemic lupus erythematosus 160 90
Autoimmune hemolytic anemia 1 0
Mixed connective tissue disease 1 1
Psoriasis 1 0
Psoriatic arthritis 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 14
Moderate 26
Mild 25
None 25

Commonly reported side effects and conditions associated with Belimumab

Side effect Patients
Fatigue 11
Headaches 9
Nausea 9
Fever 4
Whole body ache 4
Diarrhea 3

Show all 84 reported side effects

Dosages

Based on patients currently taking Belimumab

Dosage Patients
400 mg every 4 weeks 7
200 mg weekly 3
120 mg every 4 weeks 2
400 mg every 2 weeks 2
1 other monthly 1
1 hr every 4 weeks 1
1 other every 4 weeks 1
10 mg every 2 weeks 1
50 mg monthly 1
200 mg every 4 weeks 1

See all 22 dosages

Why patients stopped taking Belimumab

Multiple reasons could be selected

Reason Patients
Did not seem to work 22
Side effects too severe 13
Doctor's advice 12
Expense 8
Other 7
Course of treatment ended 5
Personal research 2
Change in health plan coverage 1
See all 50 patients who've stopped taking Belimumab

Duration

Currently taking Belimumab

Duration Patients
Less than 1 month 1
1 - 6 months 5
6 months - 1 year 5
1 - 2 years 5
2 - 5 years 13
5 - 10 years 2
10 years or more 1

Stopped taking Belimumab

Duration Patients
Less than 1 month 13
1 - 6 months 13
6 months - 1 year 9
1 - 2 years 6
2 - 5 years 8
5 - 10 years 1
Adherence
Adherence Evaluations
Always 80
Usually 2
Sometimes 3
Never taken as prescribed 5
Burden
Burden Evaluations
Very hard to take 16
Somewhat hard to take 16
A little hard to take 28
Not at all hard to take 30
Cost per month
Cost per month Evaluations
$200+ 12
$100-199 2
$50-99 4
$25-49 3
< $25 29
Not specified 40

What people switch to and from

Patients started taking Belimumab after stopping:

Treatment Patients
Methotrexate (Apo-Methotrexate) 11
Prednisone (Deltasone) 9
Mycophenolate mofetil (CellCept) 8
Azathioprine (Imuran) 4
Hydroxychloroquine (Plaquenil) 4

Show all 9 treatments patients report switching from

Patients stopped taking Belimumab and switched to:

Treatment Patients
Hydroxychloroquine (Plaquenil) 4
Rituximab (Rituxan) 4
Mycophenolate mofetil (CellCept) 3
Prednisone (Deltasone) 3
Azathioprine (Imuran) 1

Show all 12 treatments patients report switching to

Last updated:

2 patient evaluations for Belimumab

Jul 24, 2013 (Started Aug 30, 2012)

  • Effectiveness
    Slight (for systemic lupus erythematosus)
  • Side effects
    Mild (headaches, nausea)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 580 mg Monthly

Oct 1, 2012 (Started Aug 30, 2012)

  • Effectiveness
    Can’t tell (for systemic lupus erythematosus)
  • Side effects
    Moderate (headaches, nausea)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 580 mg Monthly

  • 0 helpful marks

Nov 22, 2012 (Started Sep 01, 2012)

  • Effectiveness
    Major (for systemic lupus erythematosus)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 798 mg Monthly
Advice & Tips: Awesome medicine. Cleared upy rashes in a heart beat and gave me all my energy back!!! i am only stopping temporarily due to hip surgery complications!!!! Burden due to time taken off work for the treatment-plan on at least 2-3 hours for infusion-- but, well worth it!!! But, very expensive. My insurance covered it all-- but it costs aprox 15,000 and that's what my insurance actually paid too
Cost: < $25 monthly

  • 3 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Belimumab